Teneligliptin : expectations for its pleiotropic action.

@article{Morishita2015TeneligliptinE,
  title={Teneligliptin : expectations for its pleiotropic action.},
  author={Ryuichi Morishita and Hironori Nakagami},
  journal={Expert opinion on pharmacotherapy},
  year={2015},
  volume={16 3},
  pages={417-26}
}
INTRODUCTION The main aim in the management of diabetes mellitus is to prevent the development of its complications. Large fluctuations in glucose levels may increase the risk of complications, so improved control of glucose fluctuations, in addition to management of chronic hyperglycemia, could represent an important goal in diabetes pharmacotherapy. AREAS COVERED Pre-clinical and clinical studies suggest that poor control of blood glucose fluctuations contributes to progression of diabetic… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Efficacy and safety of teneligliptin

Indian journal of endocrinology and metabolism • 2017
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 39 references

Teneligliptin for the treatment of type 2 diabetes.

Drugs of today • 2013
View 17 Excerpts
Highly Influenced

A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site.

Biochemical and biophysical research communications • 2013
View 4 Excerpts
Highly Influenced

A review of gliptins for 2014.

Expert opinion on pharmacotherapy • 2015
View 1 Excerpt

Metabolism and disposition of the dipeptidyl peptidase IV inhibitor teneligliptin in humans.

Xenobiotica; the fate of foreign compounds in biological systems • 2014
View 1 Excerpt

Pharmacokinetics of teneligliptin in Teneligliptin Expert Opin

A Halabi, H Maatouk, KE Siegler
Xenobiotica • 2014

Similar Papers

Loading similar papers…